Doctors: Can a Nice Doctor Make Treatments More Effective?

Connecting with patients doesn ’ t just make them think someone cares. It can make a difference for health outcomes.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Doctors Allergies Placebos Itching Source Type: news

Related Links:

A new U.S. study of groups of Latino youth with asthma sheds light on potential health disparities. Puerto Rican children were less likely than Mexican kids to use asthma inhalers regularly, researchers found.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news
Conclusions: PTX3 might have a thrombophilic activity and enhance TF expression in moDCs under low-shear conditions. Furthermore, suppression of moDC-associated hypercoagulability by C1-inh might be partly ascribed to its inhibitory effect on PTX3.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Conclusion: High sBT levels may help to identify patients at increased risk of more severe anaphylaxis, prompting physicians to initiate immediate therapy to avoid further acute episodes.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Peanut allergy is considered to be the most common cause for food-induced anaphylaxis. Currently, no approved treatment is available. Avoidance is the only measure to prevent anaphylactic reactions to peanuts. T-helper cells are of special importance for the sensitization process and the maintenance of allergic inflammation. Identifying markers of allergen-specific T-cell responses may help to develop novel treatment approaches. Therefore, we aimed to define new T-cell target genes in Ara h 2-specific T cells and to investigate the possibility of using them as biomarkers of peanut allergy in peripheral blood mononuclear ce...
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Conclusion: In our experience, 98.3% of 122 RDDs were completed. We found that RDD was safe and effective in this the largest series of RDD with chemotherapeutics in our country.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Conclusion: A novel stable DBPCFC matrix for milk and raw egg has been developed that allows convenient use at the patients ’ home.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Relationships found to be key to happiness; having friends at work impacts physician happiness
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news
Conditions:   Tuberculosis;   Pulmonary Tuberculosis Interventions:   Drug: Pravastatin;   Drug: Rifafour;   Dietary Supplement: Vitamin B6 Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Which factors should be considered before escalating treatments in children with severe therapy-resistant asthma?Current Opinion in Allergy and Clinical Immunology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Allergy & Clinical Immunology Journal Article Source Type: news
FDA busted two manufacturers of silicone gel-filled breast implants this week for failure to comply with post-approval study requirements. The agency sent warning letters to Irvine, CA-based Mentor Worldwide, a unit of Johnson &Johnson, and to Santa Barbara, CA-based Sientra for deficiencies in each company's post-approval study for silicone breast implant approvals. Breast implants have been a source of contention between patient advocacy groups, industry, and FDA for decades. Implants were banned from the U.S. market from 1992 to 2006, and the devices have been the cause of an over...
Source: MDDI - Category: Medical Devices Authors: Tags: Regulatory and Compliance Source Type: news
More News: Allergy | Allergy & Immunology | Health | National Institute for Health and Clinical Excelle